Optimization of recombinant vaccinia-based ELISPOT assay

Journal of Immunological Methods

Volumn 283, Issue 1-2, 2003, Pages 281-289

  Shata, Mohamed Tarek ^a   Shan, Mei Mei ^a   Tricoche, Nancy ^a   Talal, Andrew ^b   Perkus, Marion ^c   Prince, Alfred ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Virogenetics Inc   (United States)

Author keywords

Cidofovir; ELISPOT; Recombinant vaccinia

Indexed keywords

CIDOFOVIR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

VACCINIA VIRUS;

EID: 0345059075     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2003.10.002     Document Type: Article

References (35)

1. Baker R.O., Bray M., Huggins J.W. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antivir. Res. 57:2003;13-23.
2. Cherrington J.M., Allen S.J., McKee B.H., Chen M.S. Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases beta and gamma. Biochem. Pharmacol. 48:1994;1986-1988.
3. Cohard M., Liu Q., Perkus M., Gordon E., Brotman B., Prince A.M. Hepatitis C virus-specific CTL responses in PBMC from chimpanzees with chronic hepatitis C: determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC). J. Immunol. Methods. 214:1998;121-129.
4. Freeman A.J., Pan Y., Harvey C.E., Post J.J., Law M.G., White P.A., Rawlinson W.D., Lloyd A.R., Marinos G., Ffrench R.A. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J. Hepatol. 38:2003;349-356.
5. Goepfert P.A., Bansal A., Edwards B.H., Ritter G.D. Jr., Tellez I., McPherson S.A., Sabbaj S., Mulligan M.J. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J. Virol. 74:2000;10249-10255.
6. Herr W., Protzer U., Lohse A.W., Gerken G., Meyer zum Buschenfelde K.H., Wolfel T. Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure. J. Infect. Dis. 178:1998;260-265.
7. Ho H.T., Woods K.L., Bronson J.J., De Boeck H., Martin J.C., Hitchcock M.J. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2- (phosphonylmethoxy)propyl]cytosine. Mol. Pharmacol. 41:1992;197-202.
8. Johnston J.B., McFadden G. Poxvirus immunomodulatory strategies: current perspectives. J. Virol. 77:2003;6093-6100.
9. Kern E.R., Hartline C., Harden E., Keith K., Rodriguez N., Beadle J.R., Hostetler K.Y. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir. Antimicrob. Agents Chemother. 46:2002;991-995.
10. Lalvani A., Brookes R., Hambleton S., Britton W.J., Hill A.V., McMichael A.J. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186:1997;859-865.
11. Lalvani A., Brookes R., Wilkinson R.J., Malin A.S., Pathan A.A., Andersen P., Dockrell H., Pasvol G., Hill A.V. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 95:1998;270-275.
12. Larsson M., Jin X., Ramratnam B., Ogg G.S., Engelmayer J., Demoitie M.A., McMichael A.J., Cox W.I., Steinman R.M., Nixon D., Bhardwaj N. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS. 13:1999;767-777.
13. Lea A.P., Bryson H.M. Cidofovir. Drugs. 52:1996;225-230. (discussion 231).
14. McCutcheon M., Wehner N., Wensky A., Kushner M., Doan S., Hsiao L., Calabresi P., Ha T., Tran T.V., Tate K.M., Winkelhake J., Spack E.G. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J. Immunol. Methods. 210:1997;149-166.
15. Moore M.R., Hamzeh F.M., Lee F.E., Lietman P.S. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system. Antimicrob. Agents Chemother. 38:1994;2404-2408.
16. Neyts J., Snoeck R., Schols D., Balzarini J., De Clercq E. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2- propoxymethyl)guanine (DHPG). Virology. 179:1990;41-50.
17. Nixon D.F., Townsend A.R., Elvin J.G., Rizza C.R., Gallwey J., McMichael A.J. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature. 336:1988;484-487.
18. Otova B., Votruba I., Holy A. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect. Acta Virol. 36:1992;313-319.
19. Pancholi P., Lee D.H., Liu Q., Tackney C., Taylor P., Perkus M., Andrus L., Brotman B., Prince A.M. DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee. Hepatology. 33:2001;448-454.
20. Pancholi P., Perkus M., Tricoche N., Liu Q., Prince A.M. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice. J. Virol. 77:2003;382-390.
21. Panicali D., Davis S.W., Mercer S.R., Paoletti E. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37:1981;1000-1010.
22. Perkus M.E., Limbach K., Paoletti E. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. J. Virol. 63:1989;3829-3836.
23. Prince A.M., Shata M.T. Immunoprophylaxis of hepatitis C virus infection. Clin. Liver Dis. 5:2001;1091-1103.
24. Schmittel A., Keilholz U., Scheibenbogen C. Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood. J. Immunol. Methods. 210:1997;167-174.
25. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., Sypula J., Nazarian S.H., Lucas A., McFadden G. Poxviruses and immune evasion. Annu. Rev. Immunol. 21:2003;377-423.
26. Shata M.T., Anthony D.D., Carlson N.L., Andrus L., Brotman B., Tricoche N., McCormack P., Prince A. Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees. J. Viral Hepatitis. 9:2002;400-410.
27. Shata M.T., Tricoche N., Perkus M., Tom D., Brotman B., McCormack P., Pfahler W., Lee D.-H., Tobler L.H., Busch M., Prince A.M. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology. 314:2003;601-616.
28. Smee D.F., Bray M., Huggins J.W. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. Antivir. Chem. Chemother. 12:2001;327-335.
29. Smee D.F., Sidwell R.W., Kefauver D., Bray M., Huggins J.W. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses. Antimicrob. Agents Chemother. 46:2002;1329-1335.
30. Speller S.A., Warren A.P. Ex vivo detection and enumeration of human antigen-specific CD8+ T lymphocytes using antigen delivery by a recombinant vaccinia expression vector and intracellular cytokine staining. J. Immunol. Methods. 262:2002;167-180.
31. Sun Y., Iglesias E., Samri A., Kamkamidze G., Decoville T., Carcelain G., Autran B. A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J. Immunol. Methods. 272:2003;23-34.
32. Wong D.K., Dudley D.D., Dohrenwend P.B., Lauer G.M., Chung R.T., Thomas D.L., Walker B.D. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J. Virol. 75:2001;1229-1235.
33. Xiong X., Smith J.L., Kim C., Huang E.S., Chen M.S. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase. Biochem. Pharmacol. 51:1996;1563-1567.
34. Xu J., Lori F., Lisziewicz J. Vaccinia assay for the rapid detection of functional HIV-specific CD8(+) cytotoxic T lymphocytes. J. Immunol. Methods. 276:2003;45-57.
35. Yuen L., Moss B. Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes. Proc. Natl. Acad. Sci. U. S. A. 84:1987;6417-6421.